{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:53:40Z","timestamp":1793836420546,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"New Technology Project of the First Affiliated Hospital, Anhui Medical University","award":["2014-01"],"award-info":[{"award-number":["2014-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10238-019-00596-1","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T16:01:43Z","timestamp":1573920103000},"page":"21-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities"],"prefix":"10.1007","volume":"20","author":[{"given":"Goshgar","family":"Mammadov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo Zhen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sama","family":"Samadli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang Huang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2144-9806","authenticated-orcid":false,"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,16]]},"reference":[{"key":"596_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jpeds.2016.09.052","volume":"180","author":"MH Wu","year":"2017","unstructured":"Wu MH, Lin MT, Chen HC, Kao FY, Huang SK. Postnatal risk of acquiring Kawasaki disease: a nationwide birth cohort database study. J Pediatr. 2017;180:80\u20136.","journal-title":"J Pediatr"},{"key":"596_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2188\/jea.JE20140089","volume":"25","author":"N Makino","year":"2015","unstructured":"Makino N, Nakamura Y, Yashiro M, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011\u20132012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25:239\u201345.","journal-title":"J Epidemiol."},{"key":"596_CR3","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, et al. American heart association rheumatic fever, endocarditis, and kawasaki disease committee of the council on cardiovascular disease in the young; council on cardiovascular and stroke nursing; council on cardiovascular surgery and anesthesia; and council on epidemiology and prevention. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation. 2017;135:e927\u201399.","journal-title":"Circulation"},{"key":"596_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2017.05.019","volume":"471","author":"P Hu","year":"2017","unstructured":"Hu P, Jiang GM, Wu Y, et al. TNF-\u03b1 is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease. Clin Chim Acta. 2017;471:76\u201380.","journal-title":"Clin Chim Acta"},{"key":"596_CR5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","volume":"94","author":"H Kato","year":"1996","unstructured":"Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379\u201385.","journal-title":"Circulation."},{"key":"596_CR6","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113:2606\u201312.","journal-title":"Circulation"},{"key":"596_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149:237\u201340.","journal-title":"J Pediatr"},{"key":"596_CR8","doi-asserted-by":"crossref","first-page":"54357","DOI":"10.18632\/oncotarget.17530","volume":"8","author":"L Bai","year":"2017","unstructured":"Bai L, Feng T, Yang L, et al. Retrospective analysis of risk factors associated with Kawasaki disease in China. Oncotarget. 2017;8:54357\u201363.","journal-title":"Oncotarget."},{"key":"596_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/INF.0b013e3181f6fe2a","volume":"30","author":"M Eladawy","year":"2011","unstructured":"Eladawy M, Dominguez SR, Anderson MS, Glod\u00e9 MP. Abnormal liver panel in acute kawasaki disease. Pediatr Infect Dis J. 2011;30:141\u20134.","journal-title":"Pediatr Infect Dis J."},{"key":"596_CR10","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.echo.2016.03.017","volume":"29","author":"T Kobayashi","year":"2016","unstructured":"Kobayashi T, Fuse S, Sakamoto N, et al. Z Score Project Investigators. A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population. J Am Soc Echocardiogr. 2016;29:794\u2013801.","journal-title":"J Am Soc Echocardiogr."},{"key":"596_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10238-018-00544-5","volume":"19","author":"Y Wu","year":"2019","unstructured":"Wu Y, Liu FF, Xu Y, et al. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm. Clin Exp Med. 2019;19:173\u201381.","journal-title":"Clin Exp Med."},{"key":"596_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","volume":"364","author":"JC Burns","year":"2004","unstructured":"Burns JC, Glod\u00e9 MP. Kawasaki syndrome. Lancet. 2004;364:533\u201344.","journal-title":"Lancet"},{"key":"596_CR13","first-page":"62","volume":"15","author":"E Tizard","year":"2005","unstructured":"Tizard E. Complications of Kawasaki disease. Curr. Paediatr. 2005;15:62\u20138.","journal-title":"Paediatr."},{"key":"596_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/15513818509026899","volume":"4","author":"G Ohshio","year":"1985","unstructured":"Ohshio G, Furukawa F, Fujiwara H, Hamashima Y. Hepatomegaly and splenomegaly in Kawasaki disease. Pediatr Pathol. 1985;4:257\u201364.","journal-title":"Pediatr Pathol."},{"key":"596_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0022-3476(05)80239-2","volume":"120","author":"B Bader-Meunier","year":"1992","unstructured":"Bader-Meunier B, Hadchouel M, Fabre M, Arnoud MD, Dommergues JP. Intrahepatic bile duct damage in children with Kawasaki disease. J Pediatr. 1992;120:750\u20132.","journal-title":"J Pediatr"},{"key":"596_CR16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/INF.0b013e31822d4f56","volume":"30","author":"AH Tremoulet","year":"2011","unstructured":"Tremoulet AH, Jain S, Chandrasekar D, Sun X, Sato Y, Burns JC. Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J. 2011;30:1022\u20136.","journal-title":"Pediatr Infect Dis J."},{"key":"596_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jinf.2003.08.002","volume":"48","author":"Y Okada","year":"2004","unstructured":"Okada Y, Minakami H, Tomomasa T, et al. Serum procalcitonin concentration in patients with Kawasaki disease. J Infect. 2004;48:199\u2013205.","journal-title":"J Infect"},{"key":"596_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12969-019-0352-3","volume":"17","author":"S Samadli","year":"2019","unstructured":"Samadli S, Liu FF, Mammadov G, et al. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease. Pediatr Rheumatol Online J. 2019;17:53.","journal-title":"Pediatr Rheumatol Online J."},{"key":"596_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10238-017-0451-8","volume":"17","author":"F Si","year":"2017","unstructured":"Si F, Wu Y, Gao F, Feng S, Liu R, Yi Q. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease. Clin Exp Med. 2017;17:451\u20137.","journal-title":"Clin Exp Med."},{"key":"596_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10238-018-0513-6","volume":"19","author":"Y Su","year":"2019","unstructured":"Su Y, Feng S, Luo L, Liu R, Yi Q. Association between IL-35 and coronary arterial lesions in children with Kawasaki disease. Clin Exp Med. 2019;19:87\u201392.","journal-title":"Clin Exp Med."},{"issue":"8","key":"596_CR21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1253\/jcj.43.741","volume":"43","author":"SHIGERU AMANO","year":"1979","unstructured":"Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J. 1979;43:741-8.","journal-title":"Japanese Circulation Journal"},{"key":"596_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1034\/j.1600-0528.2002.017404.x","volume":"174","author":"S Seki","year":"2000","unstructured":"Seki S, Habu Y, Kawamura T, et al. The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag\u2009+\u2009T cells in T helper 1 immune responses. Immunol Rev. 2000;174:35\u201346.","journal-title":"Immunol Rev."},{"key":"596_CR23","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1096\/fj.12-205625","volume":"26","author":"K Ishihara","year":"2012","unstructured":"Ishihara K, Miyazaki A, Nabe T, et al. Group IVA phospholipase A2 participates in the progression of hepatic fibrosis. FASEB J. 2012;26:4111\u201321.","journal-title":"FASEB J."},{"key":"596_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","volume":"25","author":"A Zalewski","year":"2005","unstructured":"Zalewski A, Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol. 2005;25:923\u201331.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"596_CR25","first-page":"145","volume":"12","author":"C Tanaseanu","year":"2007","unstructured":"Tanaseanu C, Tudor S, Tamsulea I, Marta D, Manea G, Moldoveanu E. Vascular endothelial growth factor, lipoporotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erithematosus. Eur J Med Res. 2007;12:145\u201351.","journal-title":"Eur J Med Res."},{"key":"596_CR26","first-page":"267","volume":"32","author":"M Prete","year":"2014","unstructured":"Prete M, Fatone MC, Vacca A, Racanelli V, Perosa F. Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature. Clin Exp Rheumatol. 2014;32:267\u201374.","journal-title":"Clin Exp Rheumatol"},{"key":"596_CR27","doi-asserted-by":"publisher","first-page":"6130725","DOI":"10.1155\/2017\/6130725","volume":"2017","author":"M Sauer","year":"2017","unstructured":"Sauer M, Do\u00df S, Ehler J, Mencke T, Wagner NM. Procalcitonin impairs liver cell viability and function in vitro: a potential new mechanism of liver dysfunction and failure during sepsis? Biomed Res Int. 2017;2017:6130725.","journal-title":"Biomed Res Int"},{"key":"596_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2013.04.004","volume":"67","author":"N Principi","year":"2013","unstructured":"Principi N, Rigante D, Esposito S. The role of infection in Kawasaki syndrome. J Infect. 2013;67:1\u201310.","journal-title":"J Infect"},{"key":"596_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1086\/598638","volume":"29","author":"M Hall","year":"1999","unstructured":"Hall M, Hoyt L, Ferrieri P, Schlievert PM, Jenson HB. Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. Clin Infect Dis. 1999;29:586\u20139.","journal-title":"Clin Infect Dis"},{"key":"596_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2249.2006.03015.x","volume":"143","author":"K Matsubara","year":"2006","unstructured":"Matsubara K, Fukaya T, Miwa K, et al. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease. Clin Exp Immunol. 2006;143:427\u201334.","journal-title":"Clin Exp Immunol"},{"key":"596_CR31","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1442-200X.1994.tb03277.x","volume":"36","author":"H Kanegane","year":"1994","unstructured":"Kanegane H, Tsuji T, Seki H, et al. Kawasaki disease with a concomitant primary Epstein-Barr virus infection. Acta Paediatr Jpn. 1994;36:713\u20136.","journal-title":"Acta Paediatr Jpn"},{"key":"596_CR32","first-page":"1400","volume":"132","author":"JA Embil","year":"1985","unstructured":"Embil JA, McFarlane ES, Murphy DM, Krause VW, Stewart HB. Adenovirus type 2 isolated from a patient with fatal Kawasaki disease. Can Med Assoc J. 1985;132:1400.","journal-title":"Can Med Assoc J"},{"key":"596_CR33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/BF01957946","volume":"151","author":"K Hagiwara","year":"1992","unstructured":"Hagiwara K, Komura H, Kishi F, Kaji T, Yoshida T. Isolation of human herpesvirus-6 from an infant with Kawasaki disease. Eur J Pediatr. 1992;151:867\u20138.","journal-title":"Eur J Pediatr"},{"key":"596_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/00006454-198501000-00024","volume":"4","author":"D Johnson","year":"1985","unstructured":"Johnson D, Azimi P. Kawasaki disease associated with Klebsiella pneumoniae bacteremia and parainfluenza type 3 virus infection. Pediatr Infect Dis. 1985;4:100.","journal-title":"Pediatr Infect Dis."},{"key":"596_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/infdis\/148.1.177","volume":"148","author":"S Matsuno","year":"1983","unstructured":"Matsuno S, Utagawa E, Sugiura A. Association of rotavirus infection with Kawasaki syndrome. J Infect Dis. 1983;148:177.","journal-title":"J Infect Dis"},{"key":"596_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/jch.12394","volume":"16","author":"P Hu","year":"2014","unstructured":"Hu P, Wang J, Fan XC, Hu B, Lu L. Hypertension triggers the rupture of coronary artery aneurysm in an 8-year-old boy with Kawasaki disease. J Clin Hypertens (Greenwich). 2014;16:766\u20137.","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"596_CR37","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1111\/ijd.13122","volume":"55","author":"P Hu","year":"2016","unstructured":"Hu P, Guan Y, Fan XC, Lu FY, Song LM. Incomplete Kawasaki disease induced by measles in a 6-month-old male infant. Int J Dermatol. 2016;55:e34\u20136.","journal-title":"Int J Dermatol"},{"key":"596_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10238-019-00547-w","volume":"19","author":"Y Peng","year":"2019","unstructured":"Peng Y, Liu X, Duan Z, et al. Prevalence and characteristics of arthritis in Kawasaki disease: a Chinese cohort study. Clin Exp Med. 2019;19:167\u201372.","journal-title":"Clin Exp Med."},{"key":"596_CR39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/INF.0b013e3181dba70b","volume":"29","author":"A Jordan-Villegas","year":"2010","unstructured":"Jordan-Villegas A, Chang ML, Ramilo O, Mej\u00edas A. Concomitant respiratory viral infections in children with Kawasaki disease. Pediatr Infect Dis J. 2010;29:770\u20132.","journal-title":"Pediatr Infect Dis J."},{"key":"596_CR40","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.5114\/amsad.2018.74522","volume":"3","author":"K Ramphul","year":"2018","unstructured":"Ramphul K, Mejias SG. Kawasaki disease: a comprehensive review. Arch Med Sci Atheroscler Dis. 2018;3:e41\u20135.","journal-title":"Arch Med Sci Atheroscler Dis."},{"key":"596_CR41","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2165\/00003495-199958050-00004","volume":"58","author":"Z Onouchi","year":"1999","unstructured":"Onouchi Z, Kawasaki T. Overview of pharmacological treatment of Kawasaki disease. Drugs. 1999;58:813\u201322.","journal-title":"Drugs."},{"key":"596_CR42","first-page":"CD004175","volume":"4","author":"JH Baumer","year":"2006","unstructured":"Baumer JH, Love SJ, Gupta A, Haines LC, Maconochie I, Dua JS. Salicylate for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2006;4:CD004175.","journal-title":"Cochrane Database Syst Rev."},{"key":"596_CR43","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0022-3476(96)80140-5","volume":"128","author":"T Matsubara","year":"1996","unstructured":"Matsubara T, Mason W, Kashani IA, Kligerman M, Burns JC. Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. J Pediatr. 1996;128:701\u20133.","journal-title":"J Pediatr"},{"key":"596_CR44","first-page":"67","volume":"33","author":"JH Lee","year":"1992","unstructured":"Lee JH, Hung HY, Huang FY. Kawasaki disease with Reye syndrome: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1992;33:67\u201371.","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi."},{"key":"596_CR45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cld.2007.06.004","volume":"11","author":"GP Aithal","year":"2007","unstructured":"Aithal GP, Day CP. Nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Clin Liver Dis. 2007;11:563\u201375.","journal-title":"Clin Liver Dis"},{"key":"596_CR46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11596-011-0587-9","volume":"31","author":"J Chen","year":"2011","unstructured":"Chen J, Liu Y, Liu W, Wu Z. A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in Chinese children. J Huazhong Univ Sci Technolog Med Sci. 2011;31:705.","journal-title":"J Huazhong Univ Sci Technolog Med Sci."},{"key":"596_CR47","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jfma.2015.03.012","volume":"115","author":"MT Lin","year":"2016","unstructured":"Lin MT, Chang CH, Sun LC, et al. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease. J Formos Med Assoc. 2016;115:350\u20135.","journal-title":"J Formos Med Assoc"},{"key":"596_CR48","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s10067-016-3370-2","volume":"35","author":"Y Tang","year":"2016","unstructured":"Tang Y, Yan W, Sun L, et al. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population. Clin Rheumatol. 2016;35:2771\u20136.","journal-title":"Clin Rheumatol"},{"key":"596_CR49","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10067-018-4393-7","volume":"38","author":"W Hua","year":"2019","unstructured":"Hua W, Ma F, Wang Y, et al. A new scoring system to predict Kawasaki disease with coronary artery lesions. Clin Rheumatol. 2019;38:1099\u2013107.","journal-title":"Clin Rheumatol"},{"key":"596_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2188\/jea.JE20140128","volume":"25","author":"M Kuwabara","year":"2015","unstructured":"Kuwabara M, Yashiro M, Kotani K, et al. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. J Epidemiol. 2015;25:189\u201393.","journal-title":"J Epidemiol."},{"key":"596_CR51","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/bja\/85.4.599","volume":"85","author":"JP Nicholson","year":"2000","unstructured":"Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85:599\u2013610.","journal-title":"Br J Anaesth"},{"key":"596_CR52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1054\/clnu.2001.0439","volume":"20","author":"PE Ballmer","year":"2001","unstructured":"Ballmer PE. Causes and mechanisms of hypoalbuminaemia. Clin Nutr. 2001;20:271\u20133.","journal-title":"Clin Nutr"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00596-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-019-00596-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00596-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:45:21Z","timestamp":1605401121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-019-00596-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,16]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1007\/s10238-019-00596-1","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,16]]},"assertion":[{"value":"26 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research was in compliance with the Declaration of Helsinki. Approval for this research was acquired from the Medical Ethic Committee of the First Affiliated Hospital of Anhui Medical University (Code number; LLSC\/20150009).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}